EULAR publishes the Annals of the Rheumatic Diseases and RMD Open covering rheumatology medicine and research.
ARD [*] is the original research journal in rheumatology with an impact factor of 16.102. RMD Open [*] is an online only, open access journal that aims to provide rapid publication of research for authors that are required (or wish) to publish open access.
Annals of the Rheumatic
Join EULAR President Prof. Iain McInnes and ARD Editor in Chief Prof. Josef Smolen to find out about the ARD Journal[*]: Annals of the Rheumatic Diseases (ARD) is a Plan S compliant Transformative Journal.
Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.
ARD is an official journal of EULAR.
ARD Editor: Josef Smolen, Vienna, Austria [*]: First published in 1939, and the official journal of EULAR since 2000, Annals of the Rheumatic Diseases [*] (ARD) is an international peer reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders.
ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions. The journal also publishes review articles, editorials, viewpoints and thought-provoking articles on developments in the field. Correspondence is encouraged. Sign up for email alerts [*] for ARD.
June 2017: EULAR and BMJ, a leading healthcare knowledge provider, is pleased to announce Josef Smolen as the new editor of Annals of the Rheumatic Diseases (ARD).
RMD Open: Editor: Bernard Combe, Montpellier, France: RMD Open[*] is an online only, open access journal that publishes high quality peer reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies that add to the literature are all considered.
RMD Open has a Scopus CiteScore[*] of 3.47 and is indexed in various databases, including the Emerging Sources Citation Index, Scopus and PubMed Central.
Click here[*] to read the latest articles and submit your paper here[*]. Sign up for email alerts[*] for RMD Open.
ARD lay summaries for patients and non-clinicians
ARD provides short research summaries [*] for patients and non-clinicians to accompany selected key research papers published in the journal. These aim to clearly explain the results of the research studies as well as any implications for treatment of the specific condition. The summaries are written in plain language in a consistently structured format and checked for accuracy and readability by expert rheumatologists and people from EULAR’s network of patient research partners.
RMD Open: Discount code
If you picked up an author discount code at EULAR Congress, don't forget to use it for your next submission to RMD Open.
Journals on social media
You can follow both journals on Twitter [*] and Facebook [*], and listen to free occasional audio podcasts from ARD [*] and RMD Open [*].